Irina Vasil’evna Stanoevich

Dr. Irina Vasil’evna Stanoevich


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2021 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
VSV. A. Solodkiy
V. A. Solodkiy
GAG. G. Akhaladze
G. G. Akhaladze
EGE. N. Grebenkin
E. N. Grebenkin
SGS. V. Goncharov
S. V. Goncharov
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
OIO. A. Ivanova
O. A. Ivanova
Aim. To improve the surgical treatment results among patients with synchronous liver metastasis of colorectal cancer. Materials and methods. From 2012 to 2019, the analysis of the results of treatment of 60 patients with colorectal cancer and synchronous metastatic liver disease was carried out. The study sample was divided into 2 groups of patients. The group 1 consisted of 30 patients who got simultaneous resection of liver metastases and primary colorectal cancer. The group 2 consisted of other 30 patients who got stage resections: surgery for the primary tumor at the first stage, and liver surgery for metastases at the second.Results. The median operative time was 340 ± 21.1 minutes in the group 1. In the group 2 it was 255 ± 21.1 minutes and only the liver resection stage was assessed. The median blood loss in patients of the group 1 was 520,0 [200,0;800,1] ml, in the group 2 it was 500,0 [175,0;1300,0] ml. In general, we identified 5 cases of complications. In the postoperative period, 4 patients died. The average follow-up period is 23 months. One-year survival in group 1 was 92.6%, in group 2 – 100%, three-year – 85.2% and 89.6%. One-year disease-free survival in group 1 is 70%, in group 2 – 83.3%, three-year disease-free survival – 43.3% and 36.7%.Overall and disease-free survival rates didn’t differ significantly between the two treatment strategies. We detected significant effect on the disease-free and overall survival of regional lymph nodes metastasis (both p < 0.05).Conclusion. The long-term and immediate results of simultaneous surgery of synchronous liver metastasis of colorectal cancer are comparable to the results of the staged method of treatment. It indicates the safety and effectiveness of simultaneous procedure.

23 February 2023 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
ISIrina Stanoevich
Irina Stanoevich
VKV. V. Khvostovoy
V. V. Khvostovoy
ETE. I. Tishina
E. I. Tishina
VDV. I. Dyachkova
V. I. Dyachkova
DPDmitry V Petrochenko
Dmitry V Petrochenko
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
Purpose. To reflect the current understanding of the frequency, molecular mechanisms, and means of overcoming alopecia in cancer patients, taking into account the fundamental data of recent years on the physiology of the hair follicle and the pharmacological profile of the toxicity of anticancer drugs.Material and Methods. A literature search using Medline, Pubmed, etc. databases was carried out. More than 200 publications devoted to the study of alopecia were found, of which 42 were included in this review.Results. Chemotherapy-induced hair loss is a common adverse effect in cancer patients undergoing treatment. The frequency and molecular mechanism of the development of alopecia are related to the pharmacological features of the drug-based treatments, initial nutritional premorbid status, and predisposing polymorphisms of genes involved in drug conversion and excretion. Focal or diffuse alopecia may be the first sign of malignant growth within the paraneoplastic syndrome, primary or metastatic malignancies of the scalp, or be a manifestation of nutritional insufficiency. Baldness negatively affects the psycho-emotional state of patients, exacerbating depressive disorders, anxiety, reducing self-esteem and adherence to treatment. Thus, prevention or rapid overcoming of alopecia can significantly improve the quality of life of cancer patients. The use of scalp cooling or ‘cold caps’ is proven to be an effective way of combating chemotherapy-induced hair loss.Conclusion. Further studies are needed to prevent and treat alopecia in cancer patients.

15 July 2022 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
APAlexandr N. Perepelevskiy
Alexandr N. Perepelevskiy
USUgljesa S. Stanojevic
Ugljesa S. Stanojevic
VLViktor A. Lazarenko
Viktor A. Lazarenko
EGEgor N. Grebenkin
Egor N. Grebenkin
OSOlga E. Sumina
Olga E. Sumina
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
Background. Morphological verification of central and peripheral focal lung neoplasms is a difficult task for modern minimally invasive methods of differential diagnosis. The use of transthoracic trepanobiopsy of lung neoplasms under the control of computed tomography (CT) allows you to obtain informative, histological material and make a correct diagnosis. Aim. The aim of the study was to determine the possibility and safety of performing transthoracic trepanobiopsy of lung tumors under the control of CT in patients who are on an outpatient appointment in a third-level institution in order to obtain informative histological material. Materials and methods. From January 2020 to April 2021, 65 patients underwent transthoracic trepanobiopsy of focal lung neoplasms under the control of CT on an outpatient basis in the polyclinic department of the Ostroverkhov Kursk Cancer Research and Clinical Center. Results. The average time spent on performing a biopsy, with preliminary marking under CT control, was 15.14.5 minutes. In 2 (3.1%) cases, the morphological material was uninformative. The informativeness of the performed trepanobiopsies for the verification of the lung tumor process was 96.9%. Complications were observed in 5 (7.6%) patients: pneumothorax in 4 (6.1%), hemoptysis in 1 (1.5%). Pneumothorax occurred mainly in patients aged 5567 years. Conclusion. The used method of transthoracic lung trepanobiopsy under CT control should be used in outpatient settings of third-level institutions for morphological confirmation of the diagnosis, since it is safe and highly informative for patients, which is confirmed by a low percentage of complications (7.6%) and allows for differential diagnosis of focal lung neoplasms at the pre-hospital stage.

15 December 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
OIO. A. Ivanova
O. A. Ivanova
GAG. G. Akhaladze
G. G. Akhaladze
SGS. V. Goncharov
S. V. Goncharov
EGE. N. Grebenkin
E. N. Grebenkin
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
VSV. A. Solodkiy
V. A. Solodkiy
Aim. To analyze studies focused on comparing laparoscopic and open simultaneous surgeries for synchronous metastases of colorectal cancer in the liver.Materials and methods. The electronic databases PubMed, Web of Science, Scopus, Embase, Cochrane Library were searched for the studies focused on the comparison of open and laparoscopic simultaneous surgeries for synchronous metastatic liver lesions, dated till October 20, 2020. Keywords: simultaneous resections, colorectal cancer, liver metastases, simultaneous laparoscopic.Results. Meta-analysis contains the results of 1211 simultaneous surgeries for simultaneous metastases of colorectal cancer in the liver: 450 laparoscopic and 761 open surgeries. Laparoscopic surgery was characterized with lower blood loss [weighted mean difference (WMD) = -131.77, 95% CI: -232.54 to -31.00, p = 0.01], a shorter postoperative hospitalization [WMD = -2.87, 95% CI: -3.41 to -2. 33, p < 0.00001], early first bowel movement [WMD = -0.99, 95% CI: -1.40 to -0.58, p < 0.0001], early initiation of enteral feeding [WMD = -1.20, 95% CI: -2.06 to -0.33, p = 0.007]), lower incidence of postoperative complications [OR = 0.60, 95% CI: 0.46–0.80, p = 0.0004]. A statistically significant advantage of laparoscopic access was established in overall [OR = 0.80, 95% CI: 0.64–0.99, p = 0.04] and recurrence-free survival [OR = 0.73, 95% CI: 0.60–0.89, p = 0.002].Conclusion. Perioperative and distant oncologic outcomes demonstrate safety and efficacy of laparoscopic simultaneous interventions for synchronous metastases of colorectal cancer in comparison with open interventions.

14 December 2023 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
VBVladimir Konstantinovich Bozhenko
Vladimir Konstantinovich Bozhenko
SGS. V. Goncharov
S. V. Goncharov
MZM. V. Zakharenko
M. V. Zakharenko
YKYa. Yu. Kiseleva
Ya. Yu. Kiseleva
TKT. A. Karmakova
T. A. Karmakova
ЯКЯ. Ю. Киселева
Я. Ю. Киселева
Introduction. The absence of specific clinical symptoms in the early stages of colorectal cancer development leads to the fact that a quarter of patients who seek help for the first time have a metastatic stage of the disease. For the timely detection of pre-tumor disorders or hidden foci of malignancy, the possibilities of modern molecular biological technologies are being actively studied today.Aim. To develop a method for diagnosing tumor diseases of the colon based on molecular genetic analysis of morphologically unchanged intestinal epithelium distant from the focus of the tumor lesion.Materials and methods. We examined the matrix RNA (mRNA) expression profile of 63 candidate genes potentially associated with the pathogenesis of neoplastic changes in rectal mucosal samples. Samples were obtained during prophylactic and/or diagnostic video colonoscopy of 122 patients, 41 of whom had no history of breast cancer (“Normal”), 32 patients were diagnosed with breast cancer polyps (“Polyposis”) and 49 patients were diagnosed with breast cancer (“colorectal cancer”). mRNA expression was assessed by reverse transcription polymerase chain reaction.Results. Using the discriminant analysis method, it was established that the cellular material of scrapings from the rectum in the “colorectal cancer” group reliably, with a classification accuracy above 96 %, differs in expression phenotype from the “Normal” and “Polyposis” groups.Conclusion. The data obtained are a prerequisite for the development of a minimally invasive diagnostic method that can be used as part of an outpatient examination to assess the risk of colon tumor disease.

20 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
DPDmitry V Petrochenko
Dmitry V Petrochenko
ISIrina Stanoevich
Irina Stanoevich
EPEkaterina Pismennaya
Ekaterina Pismennaya
Background. The aim of the study was to develop a predictive model of anticancer drug therapy toxicity in patients with gastric cancer. Methods. The retrospective study included 100 patients with stage II-IV gastric cancer who underwent 4 chemotherapy cycles. Initial significant toxicity factors included age, gender, height, body mass, body mass index, disease stage, skeletal muscle index (SMI), as well as plasma levels of trace elements (copper, zinc, selenium, manganese) and thyroid-stimulating hormone, cancer histology type and treatment regimen. The CTCAE v5.0 scale was employed to assess the severity of adverse events. Statistical analysis and building of mathematical neural network models were carried out in SPSS Statistics (v19.0). Results. Lower SMI values were associated with higher rates of toxicity-related complications of anticancer drug therapy (р< 0.05): leukopenia, hypoproteinemia, nausea, vomiting, cardiovascular events. Anemia, thrombocytopenia, hepatic cytolysis syndrome, nausea, diarrhea, constipation and stomatitis showed a weaker correlation with SMI. An increase in TSH was associated with higher rates of thrombocytopenia, nausea and vomiting. A decrease in Cu/Zn in plasma correlated with the severity of leukopenia and diarrhea, whereas Se/Mn showed an inverse correlation with the severity of anemia. Conclusion. Sarcopenia, abnormal thyroid status and imbalances in copper, zinc, selenium and manganese in blood plasma of patients with gastric cancer may be used as predictors of increased toxicity of anticancer drug therapy.